Most women going through the menopause who sleep badly assume the explanation is hormonal. Sometimes it is. Sometimes it is not. And sometimes both things are happening at once, which is the scenario most likely to go unrecognised and untreated for years.
Obstructive sleep apnoea is a condition in which the airway partially or completely collapses during sleep, causing repeated interruptions to breathing. It is estimated to affect around 8 million people in the UK, with the majority undiagnosed. In women, diagnosis rates are particularly low, partly because the symptoms do not match the public perception of the condition, and partly because around the menopause those symptoms are almost universally attributed to hormonal change before a sleep disorder is considered.
The eight things below explain why that matters and what you can do about it.
After menopause, your risk of sleep apnoea trebles
Before the menopause, women have a significantly lower rate of obstructive sleep apnoea than men. Oestrogen and progesterone both support upper airway muscle tone and influence how the brain regulates breathing during sleep. While these hormones are present at sufficient levels, they offer a degree of protection that men do not have. After the menopause, that protection falls away. Research consistently shows that postmenopausal women have approximately three times the OSA risk of premenopausal women of the same age, bringing their risk broadly in line with men. This is not a minor statistical shift. It means that sleep apnoea, which most women never considered a realistic possibility in their thirties and forties, becomes a genuinely likely diagnosis in their fifties and sixties.
The symptoms of sleep apnoea and menopause are almost identical
This is the core problem. Both conditions produce the same cluster of symptoms: disturbed sleep, unrefreshing nights, fatigue that persists regardless of time spent in bed, night sweats, morning headaches, difficulty concentrating, low mood, and irritability. There is no symptom on the menopause checklist that is not also a symptom of obstructive sleep apnoea, and vice versa. This means that for a perimenopausal or postmenopausal woman presenting to a clinician with poor sleep and exhaustion, every complaint points equally towards hormonal change and towards a sleep disorder. Sleep apnoea is almost never considered first. The result is that many women spend years managing what is partially or primarily a sleep disorder as though it were entirely hormonal.
Sleep apnoea makes hot flushes worse
The relationship between sleep apnoea and vasomotor symptoms is not just one of symptom overlap. There is evidence of a direct causal link. Each time an apnoea event occurs, it triggers a brief activation of the sympathetic nervous system, which is the same mechanism that produces a hot flush. Women with untreated sleep apnoea report more frequent and more severe hot flushes than those without OSA, even when menopausal hormone levels are comparable. This means sleep apnoea can amplify the vasomotor symptoms of menopause independently of oestrogen levels. Treating the sleep apnoea reduces this sympathetic activation and, in many cases, reduces the frequency and intensity of hot flushes alongside improving sleep quality.
HRT alone may not resolve your sleep problems
Hormone replacement therapy is an appropriate and effective treatment for many symptoms of menopause, including disrupted sleep driven by vasomotor symptoms. For women whose sleep difficulties are primarily caused or worsened by hot flushes and night sweats, HRT often produces significant improvement. Where sleep apnoea is a concurrent driver, it may not. Women who start HRT and find that their sleep remains poor, fragmented, or unrefreshing despite good control of vasomotor symptoms should consider a sleep assessment as the next step rather than simply adjusting hormone dosing. The two conditions coexist frequently and require treatment in parallel. There is also evidence that HRT modestly reduces OSA risk by partially restoring hormonal protection of airway tone, but where significant OSA is already established, hormonal treatment alone is not sufficient to resolve it.
Perimenopause can trigger sleep apnoea before menopause is complete
Obstructive sleep apnoea does not begin the day periods stop. The perimenopause transition, which typically begins in the mid-to-late forties and can span several years, involves significant fluctuation in oestrogen and progesterone levels. These fluctuations progressively reduce the protective effect these hormones have on airway muscle tone and breathing regulation during sleep. For many women, this means sleep apnoea begins to emerge during their late forties or early fifties, while they are still having periods. If new and persistent sleep difficulties, unexplained fatigue, or worsening mood changes appear during this phase alongside other perimenopausal symptoms, the sleep disorder and the hormonal transition are often happening simultaneously. One does not rule out the other, and clinical assessment should account for both.
Standard screening tools underestimate risk in women
The STOP-BANG questionnaire, used in most clinical settings to assess sleep apnoea risk, was developed and validated primarily in male populations. It assigns risk points for factors that are more common in men: a neck circumference above 40cm, BMI above 35, loud snoring audible through a closed door, and witnessed apnoeas reported by a bed partner. Women with significant OSA frequently do not score highly on these criteria. Their snoring tends to be quieter, their apnoea events shorter and less dramatic, and their neck circumference and BMI often fall below the male-derived thresholds. They are also more likely to sleep alone or with a partner who does not witness or report apnoea events. A woman who scores 2 on STOP-BANG may still have moderate-to-severe OSA, and the score alone is not a reliable basis for reassurance.
Weight changes during menopause raise the risk further
Menopause-related changes in body composition tend to redistribute fat towards the central and abdominal areas, and towards the upper body including the neck. Fat deposits around the neck and upper airway directly increase the likelihood of obstruction during sleep. This means that even women who do not gain significant overall weight during the menopause transition may still develop increased OSA risk due to where their existing fat redistributes. Women who are also using GLP-1 medications for weight management are particularly worth considering in this context: baseline sleep testing is clinically appropriate before and during significant weight loss on these medications, since OSA severity changes substantially with body weight and treatment requirements may shift.
A home sleep test can give you a clear answer
The most direct way to find out whether sleep apnoea is contributing to your symptoms is to test for it. A home sleep test measures your breathing, blood oxygen levels, heart rate, and sleep position throughout the night using a small wrist-worn device. It does not require a GP referral, a hospital appointment, or a waiting list. You wear the device at home overnight and the data uploads automatically. A trained clinician reviews the results and provides a report with a clear explanation of what was found. If sleep apnoea is identified, you have a diagnosis. If it is not, you have ruled it out and can focus treatment entirely on hormonal and lifestyle management. Either outcome is useful. The test takes one night. The answer it provides can redirect months of inconclusive symptom management.
Home Sleep Testing
Not sure whether your symptoms are hormonal or sleep-related?
A home sleep test can rule sleep apnoea in or out overnight. No GP referral, no waiting list, clinician-reviewed results within 2 working days of your test night.
Learn about home sleep testingWhat the research shows
The link between OSA and menopause is well established in the clinical literature, even if it rarely features in the conversations most women have with their GP. Studies using objective sleep testing rather than self-report consistently find that postmenopausal women have OSA rates comparable to men of the same age, despite most clinical guidance and population awareness still framing sleep apnoea as a predominantly male condition.
One of the more striking findings across several studies is the relationship between OSA severity and hot flush frequency. Women with more severe, untreated sleep apnoea report more frequent and more intense vasomotor symptoms than those without. When sleep apnoea is treated, hot flush burden often reduces independently of any change in hormone levels. This suggests the sympathetic nervous system activation triggered by repeated apnoea events is a direct driver of vasomotor symptoms, not just a coincidental association.
The implication is that for some women, an apparent failure of HRT to adequately control hot flushes may reflect undertreated sleep apnoea rather than a need for higher hormone doses. Both should be on the table.
Why this rarely comes up in GP consultations
GP consultations for menopausal symptoms are typically focused on HRT eligibility and dosing, lifestyle modifications, and cardiovascular risk assessment. Sleep quality is usually discussed as a symptom rather than as a diagnostic avenue. The question most commonly asked is how badly the patient is sleeping, not what might be causing it at a physiological level.
Sleep study referrals from primary care for women with menopausal symptoms are uncommon. The waiting list for NHS sleep clinics in most parts of the UK currently runs to 12 to 18 months, which makes a referral a low-priority suggestion when a hormonal explanation is already plausible and HRT is available immediately.
A home sleep test sidesteps this entirely. It does not require a referral, it does not require a clinic appointment, and it does not require waiting. It requires one overnight at home and delivers a clinician-reviewed result within two working days. For women who want a clear answer rather than a working assumption, it is the most efficient route available.
A note on this article
This article is a clinician-written educational guide and is not a substitute for individual medical advice. The symptoms described overlap with a number of conditions including menopause, thyroid dysfunction, anaemia, and others. If you have persistent or significant symptoms, please speak to your GP or arrange a private clinical assessment. A formal diagnosis of obstructive sleep apnoea requires an overnight sleep study interpreted by a qualified clinician.